Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 17943820

Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cochrane Database Syst Rev
Publication date
2007 Oct 17
First author
Delbaldo C

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cochrane Database Syst Rev. 2012 Apr 18;(4):CD004569. doi: 10.1002/14651858.CD004569.pub3.
    note
    Source null
    related pmid
    22513924
    relationship
    Update in

Authors and identifiers

  1. name
    Delbaldo C
    type
    Author
  2. name
    Michiels S
    type
    Author
  3. name
    Rolland E
    type
    Author
  4. name
    Syz N
    type
    Author
  5. name
    Soria JC
    type
    Author
  6. name
    Le Chevalier T
    type
    Author
  7. name
    Pignon JP
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Delbaldo C
    type
    Author
  2. name
    Michiels S
    type
    Author
  3. name
    Rolland E
    type
    Author
  4. name
    Syz N
    type
    Author
  5. name
    Soria JC
    type
    Author
  6. name
    Le Chevalier T
    type
    Author
  7. name
    Pignon JP
    type
    Author
bibliography ids
  1. nci-bib-aeb1b326206072ee53d040c6
book metadata
content sha256
c2e1ca31f7c2524111d91b8150ed19bc152e4199661809be72be018ce66d26a7
document type
citation
dois
  1. 10.1002/14651858.CD004569.pub2
electronic publication date
display
2007 Oct 17
precision
day
year
2007
evidence scope
bibliographic_metadata_only
id
pubmed:17943820
immutable id
pubmed:17943820@c2e1ca31f7c2524111d91b8150ed19bc152e4199661809be72be018ce66d26a7
journal
abbreviation
Cochrane Database Syst Rev
issn electronic
1469-493X
issn print
1361-6137
issue
4
name
The Cochrane database of systematic reviews
nlm unique id
100909747
pages
CD004569
volume
Source null
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cochrane Database Syst Rev. 2012 Apr 18;(4):CD004569. doi: 10.1002/14651858.CD004569.pub3.
    note
    Source null
    related pmid
    22513924
    relationship
    Update in
outcomes validated
false
pmid
17943820
provenance
batch id
89a0f2206e11ca092d02
provider
NCBI PubMed ESummary
record sha256
1b6719906177b3e7281b1aaea3ce31652facfd0aa50a35cef26af09cb595e8af
response sha256
7b1c355120884a7a596bcf7b4a243dc12308b7f7f0914c3fc71b0c8e8d79c708
retrieved at
2026-09-09T23:46:16.784581+00:00
publication date
display
2007 Oct 17
precision
day
year
2007
publication types
  1. Journal Article
  2. Meta-Analysis
  3. Systematic Review
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/17943820/
title
Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease.

Preserved source evidence · Not medical advice